What we bring to you
We bring genuine depth of contract QP experience, gained from over 20 years of
continuous batch-releasing QP activity, as a permanent provisions EU/UK QP,
with eligibility attained at fist assessment through the UK ‘QP viva’ examination
process in 2006, at the Royal Society of Chemistry.
We’ve worked as QP with solid oral dosage, high speed commercial packaging
lines, small scale clinical tral packaging (including randomised / blinded supplies),
live viral vaccines, cell and virus banks, mAbs, ‘Specials’, sterile fill / finish injection
vials and pre-filled syringes, lyophilised injections, setting up of QP importation
sites into UK / EU, including UK QP oversight role for IMPs, and multiple ATMP
(HCT/P in US) products including viral vector gene therapries, hESCs, various T-
cell therapies, ex-vivo CAR-T vectors, and CRISPR-Cas9 products.
In addition, since 2010 we have performed >150 GMP site audits in UK, EU, US,
India, China, Japan, Canada, Switzerland, etc. for chemical, biological, and ATMP
drug substances and products - providing us with a broad perspective on different
approaches to achieving GMP compliance, and keeping us abreast of industry /
regulatory trends and best practices